GO:0003674 | molecular_function | 64.15% (102/159) | 0.59 | 0.0 | 1.9e-05 |
GO:0008150 | biological_process | 45.91% (73/159) | 0.67 | 4e-06 | 0.000871 |
GO:0035639 | purine ribonucleoside triphosphate binding | 15.09% (24/159) | 1.28 | 4.9e-05 | 0.002266 |
GO:0031507 | heterochromatin formation | 1.89% (3/159) | 5.24 | 6.6e-05 | 0.002341 |
GO:0045814 | negative regulation of gene expression, epigenetic | 1.89% (3/159) | 5.24 | 6.6e-05 | 0.002341 |
GO:0070828 | heterochromatin organization | 1.89% (3/159) | 5.24 | 6.6e-05 | 0.002341 |
GO:0032559 | adenyl ribonucleotide binding | 15.72% (25/159) | 1.2 | 8.3e-05 | 0.00238 |
GO:0006338 | chromatin remodeling | 2.52% (4/159) | 4.14 | 8e-05 | 0.002454 |
GO:0032553 | ribonucleotide binding | 16.98% (27/159) | 1.2 | 4.3e-05 | 0.002458 |
GO:0097367 | carbohydrate derivative binding | 16.98% (27/159) | 1.19 | 4.9e-05 | 0.002504 |
GO:0017076 | purine nucleotide binding | 16.98% (27/159) | 1.15 | 7.7e-05 | 0.002514 |
GO:0003824 | catalytic activity | 35.22% (56/159) | 0.68 | 9.4e-05 | 0.002538 |
GO:0031047 | regulatory ncRNA-mediated gene silencing | 1.89% (3/159) | 5.05 | 0.0001 | 0.002552 |
GO:0031048 | regulatory ncRNA-mediated heterochromatin formation | 1.89% (3/159) | 5.47 | 4.1e-05 | 0.00269 |
GO:0140718 | facultative heterochromatin formation | 1.89% (3/159) | 5.47 | 4.1e-05 | 0.00269 |
GO:0006346 | DNA methylation-dependent heterochromatin formation | 1.89% (3/159) | 5.47 | 4.1e-05 | 0.00269 |
GO:0080188 | gene silencing by RNA-directed DNA methylation | 1.89% (3/159) | 5.47 | 4.1e-05 | 0.00269 |
GO:0005524 | ATP binding | 13.84% (22/159) | 1.27 | 0.000113 | 0.002734 |
GO:0006325 | chromatin organization | 2.52% (4/159) | 3.96 | 0.000131 | 0.002859 |
GO:0043167 | ion binding | 23.27% (37/159) | 0.88 | 0.000147 | 0.002933 |
GO:0000166 | nucleotide binding | 16.98% (27/159) | 1.08 | 0.000169 | 0.002977 |
GO:1901265 | nucleoside phosphate binding | 16.98% (27/159) | 1.08 | 0.000169 | 0.002977 |
GO:0040029 | epigenetic regulation of gene expression | 1.89% (3/159) | 4.88 | 0.000144 | 0.002993 |
GO:0005488 | binding | 40.88% (65/159) | 0.59 | 0.000131 | 0.002997 |
GO:0030554 | adenyl nucleotide binding | 15.72% (25/159) | 1.13 | 0.000169 | 0.003224 |
GO:0007031 | peroxisome organization | 1.26% (2/159) | 6.47 | 0.00021 | 0.003311 |
GO:0009987 | cellular process | 28.3% (45/159) | 0.75 | 0.000207 | 0.003383 |
GO:0043168 | anion binding | 16.98% (27/159) | 1.06 | 0.000206 | 0.003498 |
GO:0016043 | cellular component organization | 6.29% (10/159) | 1.99 | 0.000237 | 0.003611 |
GO:0071824 | protein-DNA complex organization | 2.52% (4/159) | 3.71 | 0.000258 | 0.00381 |
GO:1901363 | heterocyclic compound binding | 16.98% (27/159) | 1.02 | 0.000314 | 0.0045 |
GO:0036094 | small molecule binding | 16.98% (27/159) | 1.01 | 0.000351 | 0.004878 |
GO:0015923 | mannosidase activity | 1.26% (2/159) | 6.05 | 0.000389 | 0.005245 |
GO:0032555 | purine ribonucleotide binding | 16.98% (27/159) | 1.21 | 3.6e-05 | 0.005522 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 1.89% (3/159) | 4.28 | 0.000504 | 0.006596 |
GO:0071840 | cellular component organization or biogenesis | 6.29% (10/159) | 1.84 | 0.000538 | 0.00685 |
GO:0031011 | Ino80 complex | 1.26% (2/159) | 5.59 | 0.000759 | 0.00915 |
GO:0097346 | INO80-type complex | 1.26% (2/159) | 5.59 | 0.000759 | 0.00915 |
GO:0016740 | transferase activity | 16.98% (27/159) | 0.94 | 0.000794 | 0.009321 |
GO:0061630 | ubiquitin protein ligase activity | 2.52% (4/159) | 3.23 | 0.000909 | 0.010409 |
GO:0061659 | ubiquitin-like protein ligase activity | 2.52% (4/159) | 3.22 | 0.000939 | 0.010494 |
GO:0000159 | protein phosphatase type 2A complex | 1.26% (2/159) | 5.35 | 0.001071 | 0.011411 |
GO:0140657 | ATP-dependent activity | 5.03% (8/159) | 1.98 | 0.001062 | 0.011584 |
GO:0008287 | protein serine/threonine phosphatase complex | 1.26% (2/159) | 5.24 | 0.001247 | 0.012689 |
GO:1903293 | phosphatase complex | 1.26% (2/159) | 5.24 | 0.001247 | 0.012689 |
GO:0051234 | establishment of localization | 8.81% (14/159) | 1.35 | 0.001278 | 0.012727 |
GO:0070603 | SWI/SNF superfamily-type complex | 1.26% (2/159) | 5.14 | 0.001435 | 0.013692 |
GO:0051179 | localization | 8.81% (14/159) | 1.33 | 0.001434 | 0.013973 |
GO:0051641 | cellular localization | 3.77% (6/159) | 2.28 | 0.001567 | 0.014649 |
GO:1904949 | ATPase complex | 1.26% (2/159) | 4.96 | 0.00185 | 0.016942 |
GO:0004842 | ubiquitin-protein transferase activity | 3.14% (5/159) | 2.51 | 0.001964 | 0.017297 |
GO:0045184 | establishment of protein localization | 3.14% (5/159) | 2.51 | 0.001964 | 0.017297 |
GO:0070727 | cellular macromolecule localization | 3.14% (5/159) | 2.47 | 0.002193 | 0.01826 |
GO:0033036 | macromolecule localization | 3.14% (5/159) | 2.47 | 0.002193 | 0.01826 |
GO:0008104 | protein localization | 3.14% (5/159) | 2.47 | 0.002193 | 0.01826 |
GO:0019787 | ubiquitin-like protein transferase activity | 3.14% (5/159) | 2.47 | 0.002233 | 0.018261 |
GO:0016755 | aminoacyltransferase activity | 3.14% (5/159) | 2.44 | 0.002398 | 0.019267 |
GO:0016758 | hexosyltransferase activity | 3.14% (5/159) | 2.42 | 0.002572 | 0.020308 |
GO:0004156 | dihydropteroate synthase activity | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0003825 | alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0008495 | protoheme IX farnesyltransferase activity | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0004567 | beta-mannosidase activity | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0003848 | 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:1901000 | regulation of response to salt stress | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0047484 | regulation of response to osmotic stress | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0033947 | mannosylglycoprotein endo-beta-mannosidase activity | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0005053 | peroxisome matrix targeting signal-2 binding | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:1901001 | negative regulation of response to salt stress | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0000268 | peroxisome targeting sequence binding | 0.63% (1/159) | 8.05 | 0.003769 | 0.023973 |
GO:0006810 | transport | 8.18% (13/159) | 1.26 | 0.003207 | 0.024896 |
GO:0019888 | protein phosphatase regulator activity | 1.26% (2/159) | 4.53 | 0.00339 | 0.025877 |
GO:0019208 | phosphatase regulator activity | 1.26% (2/159) | 4.47 | 0.003689 | 0.027698 |
GO:0097159 | organic cyclic compound binding | 23.9% (38/159) | 0.6 | 0.004759 | 0.029859 |
GO:0140096 | catalytic activity, acting on a protein | 13.21% (21/159) | 0.88 | 0.004915 | 0.03042 |
GO:0010629 | negative regulation of gene expression | 1.89% (3/159) | 3.11 | 0.005161 | 0.031519 |
GO:0006996 | organelle organization | 3.14% (5/159) | 2.15 | 0.005587 | 0.033671 |
GO:0048519 | negative regulation of biological process | 2.52% (4/159) | 2.48 | 0.005942 | 0.035345 |
GO:0065002 | intracellular protein transmembrane transport | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:0016558 | protein import into peroxisome matrix | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:0010224 | response to UV-B | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:0072663 | establishment of protein localization to peroxisome | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:0003991 | acetylglutamate kinase activity | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:0072662 | protein localization to peroxisome | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:0004134 | 4-alpha-glucanotransferase activity | 0.63% (1/159) | 7.05 | 0.007523 | 0.040066 |
GO:1902494 | catalytic complex | 3.14% (5/159) | 2.04 | 0.00778 | 0.040956 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 3.77% (6/159) | 1.84 | 0.007031 | 0.041285 |
GO:0016787 | hydrolase activity | 12.58% (20/159) | 0.86 | 0.007284 | 0.042231 |
GO:0015031 | protein transport | 2.52% (4/159) | 2.3 | 0.0091 | 0.047362 |
GO:0016462 | pyrophosphatase activity | 3.77% (6/159) | 1.74 | 0.009515 | 0.048964 |